Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Stoke Therapeutics (STOK) Asset Utilization Ratio (2022 - 2025)

Stoke Therapeutics has reported Asset Utilization Ratio over the past 4 years, most recently at 0.47 for Q4 2025.

  • Quarterly results put Asset Utilization Ratio at 0.47 for Q4 2025, up 265.97% from a year ago — trailing twelve months through Dec 2025 was 0.47 (up 265.97% YoY), and the annual figure for FY2025 was 0.53, up 265.51%.
  • Asset Utilization Ratio for Q4 2025 was 0.47 at Stoke Therapeutics, down from 0.55 in the prior quarter.
  • Over the last five years, Asset Utilization Ratio for STOK hit a ceiling of 0.56 in Q1 2025 and a floor of 0.05 in Q4 2022.
  • Median Asset Utilization Ratio over the past 4 years was 0.06 (2024), compared with a mean of 0.2.
  • Biggest five-year swings in Asset Utilization Ratio: fell 2.61% in 2024 and later skyrocketed 891.2% in 2025.
  • Stoke Therapeutics' Asset Utilization Ratio stood at 0.05 in 2022, then increased by 26.28% to 0.06 in 2023, then skyrocketed by 120.48% to 0.13 in 2024, then skyrocketed by 265.97% to 0.47 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.47 (Q4 2025), 0.55 (Q3 2025), and 0.51 (Q2 2025) per Business Quant data.